Nathan J. Palpant

Nathan J. Palpant

Auto-generated profile, based on publicly available information

Nathan J. Palpant

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2014 in Nature
Verified
Journal Article
Open access
PDF file
JCJames J. H. Chong
James J. H. Chong
XYXiulan Yang
Xiulan Yang
CDCreighton W. Don
Creighton W. Don
EMElina Minami
Elina Minami
YLYen-Wen Liu
Yen-Wen Liu
CMCharles E. Murry
Charles E. Murry
Regeneration of the heart muscle after myocardial infarction with cardiomyocytes derived from human embryonic stem cells is demonstrated in non-human primates, with the grafts showing evidence of electromechanical coupling, although they were also associated with non-fatal arrhythmias. Human pluripotent stem cells have proven cardiomyocyte-generating abilities and have been extensively investigated for repair of the injured heart. There is still a long way to go before cardiac regenerative medicine can become a reality, however. In this study Charles Murry and colleagues examine the ability of exogenously delivered human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) to engraft to the host myocardium in a non-human primate model of myocardial infarction. They demonstrate large-scale heart remuscularization, electromechanical coupling of the graft to the host heart, and vascularization of the graft from host vessels. The grafts showed evidence of electromechanical coupling, but non-fatal arrhythmias were also observed in hESC-CM-engrafted primates. Pluripotent stem cells provide a potential solution to current epidemic rates of heart failure1 by providing human cardiomyocytes to support heart regeneration2. Studies of human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) in small-animal models have shown favourable effects of this treatment3,4,5,6,7. However, it remains unknown whether clinical-scale hESC-CM transplantation is feasible, safe or can provide sufficient myocardial regeneration. Here we show that hESC-CMs can be produced at a clinical scale (more than one billion cells per batch) and cryopreserved with good viability. Using a non-human primate model of myocardial ischaemia followed by reperfusion, we show that cryopreservation and intra-myocardial delivery of one billion hESC-CMs generates extensive remuscularization of the infarcted heart. The hESC-CMs showed progressive but incomplete maturation over a 3-month period. Grafts were perfused by host vasculature, and electromechanical junctions between graft and host myocytes were present within 2 weeks of engraftment. Importantly, grafts showed regular calcium transients that were synchronized to the host electrocardiogram, indicating electromechanical coupling. In contrast to small-animal models7, non-fatal ventricular arrhythmias were observed in hESC-CM-engrafted primates. Thus, hESC-CMs can remuscularize substantial amounts of the infarcted monkey heart. Comparable remuscularization of a human heart should be possible, but potential arrhythmic complications need to be overcome.

5 August 2012 in Nature
Verified
Journal Article
Open access
PDF file
YSYuji Shiba
Yuji Shiba
SFSarah Fernandes
Sarah Fernandes
WZWei-Zhong Zhu
Wei-Zhong Zhu
DFDominic Filice
Dominic Filice
VMVeronica Muskheli
Veronica Muskheli
MLMichael A. Laflamme
Michael A. Laflamme
A guinea-pig model of cardiac injury is used to show that human embryonic stem-cell-derived cardiomyocyte grafts can electrically integrate into the injured heart, improving mechanical function and reducing spontaneous and induced ventricular tachycardia; this is a major step towards clinical adoption of cell replacement therapies for cardiovascular diseases using human cardiomyocytes. This study extends previous findings that transplantation of fetal cardiomyocytes can improve the function of infarcted hearts, despite having only a modest effect on the organ's mechanical properties. The investigators developed a guinea pig model of cardiac injury, because the heart rate of these animals is at the upper end of what is tolerable to human cardiomyocytes, and much lower than that of the mice and rats often used as models. The authors show that cardiomyocytes derived from human embryonic stem cells can integrate electrically into the guinea pig heart and protect against arrhythmias. This is the first convincing evidence that cardiomyocytes generated from cultured human embryonic stem cells can integrate into the adult heart, and is therefore a major step towards the clinical adoption of cell-replacement therapies for cardiovascular disease. Transplantation studies in mice and rats have shown that human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) can improve the function of infarcted hearts1,2,3, but two critical issues related to their electrophysiological behaviour in vivo remain unresolved. First, the risk of arrhythmias following hESC-CM transplantation in injured hearts has not been determined. Second, the electromechanical integration of hESC-CMs in injured hearts has not been demonstrated, so it is unclear whether these cells improve contractile function directly through addition of new force-generating units. Here we use a guinea-pig model to show that hESC-CM grafts in injured hearts protect against arrhythmias and can contract synchronously with host muscle. Injured hearts with hESC-CM grafts show improved mechanical function and a significantly reduced incidence of both spontaneous and induced ventricular tachycardia. To assess the activity of hESC-CM grafts in vivo, we transplanted hESC-CMs expressing the genetically encoded calcium sensor, GCaMP3 (refs 4, 5). By correlating the GCaMP3 fluorescent signal with the host ECG, we found that grafts in uninjured hearts have consistent 1:1 host–graft coupling. Grafts in injured hearts are more heterogeneous and typically include both coupled and uncoupled regions. Thus, human myocardial grafts meet physiological criteria for true heart regeneration, providing support for the continued development of hESC-based cardiac therapies for both mechanical and electrical repair.

16 June 2015 in Genome Biology
Verified
Journal Article
Open access
LSLinda Szabo
Linda Szabo
RMRobert Morey
Robert Morey
NPNathan J. Palpant
Nathan J. Palpant
PWPeter L. Wang
Peter L. Wang
NANastaran Afari
Nastaran Afari
JSJulia Salzman
Julia Salzman
Background: The pervasive expression of circular RNA is a recently discovered feature of gene expression in highly diverged eukaryotes, but the functions of most circular RNAs are still unknown. Computational methods to discover and quantify circular RNA are essential. Moreover, discovering biological contexts where circular RNAs are regulated will shed light on potential functional roles they may play. Results: We present a new algorithm that increases the sensitivity and specificity of circular RNA detection by discovering and quantifying circular and linear RNA splicing events at both annotated and un-annotated exon boundaries, including intergenic regions of the genome, with high statistical confidence. Unlike approaches that rely on read count and exon homology to determine confidence in prediction of circular RNA expression, our algorithm uses a statistical approach. Using our algorithm, we unveiled striking induction of general and tissue-specific circular RNAs, including in the heart and lung, during human fetal development. We discover regions of the human fetal brain, such as the frontal cortex, with marked enrichment for genes where circular RNA isoforms are dominant. Conclusions: The vast majority of circular RNA production occurs at major spliceosome splice sites; however, we find the first examples of developmentally induced circular RNAs processed by the minor spliceosome, and an enriched propensity of minor spliceosome donors to splice into circular RNA at un-annotated, rather than annotated, exons. Together, these results suggest a potentially significant role for circular RNA in human development.

1 October 2018 in Cell Stem Cell
Verified
Journal Article
Closed access
CFClayton E. Friedman
Clayton E. Friedman
QNQuan Nguyen
Quan Nguyen
SLSamuel W. Lukowski
Samuel W. Lukowski
AHAbbigail Helfer
Abbigail Helfer
HCHan Sheng Chiu
Han Sheng Chiu
NPNathan J. Palpant
Nathan J. Palpant

1 December 2016 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
NPNathan J Palpant
Nathan J Palpant
LPLil Pabon
Lil Pabon
CFClayton E Friedman
Clayton E Friedman
MRMeredith Roberts
Meredith Roberts
BHBrandon Hadland
Brandon Hadland
CMCharles E Murry
Charles E Murry

11 May 2018 in Genome Research
Verified
Journal Article
Open access
PDF file
QNQuan Nguyen
Quan Nguyen
SLSamuel W. Lukowski
Samuel W. Lukowski
HCHan Sheng Chiu
Han Sheng Chiu
ASAnne Senabouth
Anne Senabouth
TBTimothy J.C. Bruxner
Timothy J.C. Bruxner
JPJoseph E. Powell
Joseph E. Powell
Heterogeneity of cell states represented in pluripotent cultures has not been described at the transcriptional level. Since gene expression is highly heterogeneous between cells, single-cell RNA sequencing can be used to identify how individual pluripotent cells function. Here, we present results from the analysis of single-cell RNA sequencing data from 18,787 individual WTC-CRISPRi human induced pluripotent stem cells. We developed an unsupervised clustering method and, through this, identified four subpopulations distinguishable on the basis of their pluripotent state, including a core pluripotent population (48.3%), proliferative (47.8%), early primed for differentiation (2.8%), and late primed for differentiation (1.1%). For each subpopulation, we were able to identify the genes and pathways that define differences in pluripotent cell states. Our method identified four transcriptionally distinct predictor gene sets composed of 165 unique genes that denote the specific pluripotency states; using these sets, we developed a multigenic machine learning prediction method to accurately classify single cells into each of the subpopulations. Compared against a set of established pluripotency markers, our method increases prediction accuracy by 10%, specificity by 20%, and explains a substantially larger proportion of deviance (up to threefold) from the prediction model. Finally, we developed an innovative method to predict cells transitioning between subpopulations and support our conclusions with results from two orthogonal pseudotime trajectory methods.